The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atenolol 5mg/ml Oral Solution

5 milligram(s)/millilitre Oral solution

Syri Pharma Limited t/a Thame LaboratoriesPA22697/004/001

Main Information

Trade NameAtenolol 5mg/ml Oral Solution
Active SubstancesAtenolol
Strength5 milligram(s)/millilitre
Dosage FormOral solution
Licence HolderSyri Pharma Limited t/a Thame Laboratories
Licence NumberPA22697/004/001

Group Information

ATC CodeC07AB Beta blocking agents, selective
C07AB03 atenolol


Licence Issued09/10/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back